De novo AML with mutated RUNX1 have characteristic clinicopathologic features that include male predominance, higher frequency of SRSF2 and ASXL1 mutations, normal karyotype, and absent NPM1 mutations (68). Here, ASXL1 is linked to acute myeloid leukemia.